Beyond the Nobel: Doudna’s New Venture Aims to Democratize Gene Therapy for the ‘Forgotten’ Patients
Introduction In a bold move that could reshape the frontier of medicine, Nobel laureate Jennifer Doudna is steering her pioneering CRISPR technology toward its most personal challenge yet. Her new startup, Aurora Therapeutics, isn’t chasing blockbuster drugs for common ailments. Instead, it’s launching a mission to craft bespoke genetic cures for ultra-rare diseases, leveraging a…